Rezultaty - A. Yu. Babenko

Metformin in prediabetes: key mechanisms for the prevention of diabetes and cardiometabolic risks od A. Yu. Babenko

Dokumenty pełnotekstowe

Efficacy of sibutramine in different types of eating behavior in obese patients od G. A. Matveev, A. Yu. Babenko

Dokumenty pełnotekstowe

Use of sodium-glucose co-transporter-2 inhibitors from clinical trial results to practical application in Russia od D. A. Lebedev, A. Yu. Babenko

Dokumenty pełnotekstowe

Glucagon-like peptide-1 receptor agonists, selection within the class. The rational combination of insulin glargine 100 + lixisenatide od M. V. Martjanova, A. Yu. Babenko

Dokumenty pełnotekstowe

Fibrosis biomarkers and echocardiographic parameters in patients with type 2 diabetes depending on the degree of albuminuria od D. A. Lebedev, M. Yu. Laevskaya, A. Yu. Babenko

Dokumenty pełnotekstowe

Problems of blood glucose self-monitoring in patients with diabetes mellitus od Yu. A. Kononova, V. B. Bregovskiy, A. Yu. Babenko

Dokumenty pełnotekstowe

GLYCEMIC AND NON-GLYCEMIC EFFECTS OF EXENATIDE IN PATIENTS WITH DIABETES MELLITUS OF TYPE 2 (DM2) WITH MYOCARDIAL INFARCTION od A. Yu. BABENKO, V. A. ZYKOV, E. N. GRINEVA

Dokumenty pełnotekstowe

Main results of the ADVANCE study: clinical interpretation for endocrinologists od Alsu Gafurovna Zalevskya, A Yu Babenko, A R Volkova

Dokumenty pełnotekstowe

Biomarkers associated with atherogenesis: current status and promising areas od M. A. Magruk, A. A. Mosikyan, A. Yu. Babenko

Dokumenty pełnotekstowe

Evaluation of factors influencing adherence to treatment with sodium-glucose cotransporter type 2 inhibitor od D. A. Lebedev, A. A. Mosikian, A. Yu. Babenko

Dokumenty pełnotekstowe

Type 2 Diabetes Mellitus and Chronic Heart Failure with Midrange and Preserved Ejection Fraction: A Focus on Serum Biomarkers of Fibrosis od D. A. Lebedev, E. A. Lyasnikova, E. Yu Vasilyeva, A. Yu Babenko, E. V. Shlyakhto

Dokumenty pełnotekstowe

ASSESSMENT OF SODIUM-GLUCOSE CO-TRANSPORTER INHIBITOR IN COMBINATION WITH INSULIN ON METABOLIC PARAMETERS AND RENAL MORPHOFUNCTIONAL CHANGES IN RATS WITH EXPERIMENTAL DIABETES MELL... od D. A. Lebedev, N. P. Likhonosov, Т. P. Tuchina, V. K. Bayrasheva, A. Yu. Babenko

Dokumenty pełnotekstowe

Polymorphism of S19W of apolipoprotein A5gene in patients with type 2 diabetes mellitus - connection with metabolic parameters and triglyceride levels od S. A. Skoryukova, M. V. Kim, A. A. Bystrova, A. Yu. Babenko, E. I. Baranova, S. N. Pchelina

Dokumenty pełnotekstowe

Evaluation eff ects of IDPP4 therapy diff erent duration on the functional state of α- and β- cells in patients with type 2 diabetes mellitus od T. P. Tuchina, I. A. Kolchanova, A. R. Meltonyan, L. K. Abramyan, A. Yu. Babenko, M. M. Galagudza

Dokumenty pełnotekstowe

Molecular biomarker profile of heart failure with mid-range and preserved ejection fraction in patients with type 2 diabetes od D. A. Lebedev, E. A. Lyasnikova, A. A. Vasilyeva, E. Yu. Vasilyeva, A. Yu. Babenko, E. V. Shlyakhto

Dokumenty pełnotekstowe

Impact of obesity on echocardiographic parameters and N-terminal pro-brain natriuretic peptide levels in patients with heart failure with mid-range ejection fraction: unanswered qu... od E. A. Lyasnikova, A. A. Kuular, A. V. Pavlovskaya, A. N. Vlasenko, A. V. Kozlenok, A. Yu. Babenko, M. Yu. Sitnikova, E. V. Shlyakhto

Dokumenty pełnotekstowe

Predictors of carotid artery restenosis after carotid endarterectomy od E. P. Kolesova, E. V. Verkhovskaya, A. G. Vanyurkin, E. K. Zaykova, V. V. Kvan, O. V. Kalinina, M. A. Chernyavsky, A. L. Maslyansky, A. N. Yakovlev, A. Yu. Babenko, A. O. Konradi, E. V. Shlyakhto

Dokumenty pełnotekstowe

Features of the atherosclerotic plaque microbiome in patients after carotid endarterectomy od E. P. Kolesova, M. A. Chernyavsky, A. G. Vanyurkin, E. V. Verkhovskaya, E. K. Zaykova, O. V. Kalinina, S. I. Sitkin, A. L. Maslyansky, V. V. Kvan, E. Yu. Vasilyeva, A. N. Yakovlev, A. Yu. Babenko, A. O. Konradi, E. V. Shlyakhto

Dokumenty pełnotekstowe

THE INTERIM EXPERTS’ COUNCIL RESOLUTION ON THE EMPA-REG OUTCOME TRIAL ISSUES od M. V. Shestakova, S. A. Boytsov, O. M. Drapkina, T. Yu. Demidova, H. Drexel, M. B. Antsiferov, N. A. Petunina, N. A. Chernikova, V. Yu. Kalashnikov, T. P. Bardymova, V. K. Protasov, A. Yu. Babenko, L. A. Ruyatkina, V. V. Klimontov, V. V. Salukhov, V. V. Fadeev, Yu. A. Karpov

Dokumenty pełnotekstowe

Glycemia control and choice of antihyperglycemic therapy in patients with type 2 diabetes mellitus and COVID-19: a consensus decision of the board of experts of the Russian associa... od I. I. Dedov, N. G. Mokrysheva, M. V. Shestakova, T. V. Nikonova, A. Yu. Mayorov, G. R. Galstyan, M. Sh. Shamhalova, V. O. Barysheva, A. S. Ametov, M. B. Antsiferov, A. Yu. Babenko, T. P. Bardymova, F. V. Valeeva, A. A. Vachugova, E. N. Grineva, T. Yu. Demidova, T. P. Kiseleva, M. A. Kunicyna, T. N. Markova, A. M. Mkrtumyan, N. A. Petunina, L. A. Ruyatkina, V. V. Saluhov, L. A. Suplotova, E. L. Hadarceva, Yu. Sh. Halimov

Dokumenty pełnotekstowe